Ivermedi (შპს ივერმედი) — Georgia Financials

Georgia Financials

panel 2026-09-21Ask

Ivermedi (შპს ივერმედი) — Georgia Financials

separate · GEL, thousands

Line item	2017	2018	2019	2020	2021	2022	2023	2024	CAGR
Total Revenue	38,283	37,807	43,045	39,797	46,802	38,550	47,124	45,937	+2.6%
Total COGS	27,433	28,049	32,379	30,704	36,910	30,554	36,094	35,869	+3.9%
Gross Profit	10,850	9,758	10,666	9,093	9,892	7,996	11,030	10,068	-1.1%
Gross Margin	28.3%	25.8%	24.8%	22.8%	21.1%	20.7%	23.4%	21.9%
	6,669	6,703	7,116	5,789	6,404	7,610	7,901	11,163	+7.6%
EBITDA	4,181	3,055	3,550	3,304	3,488	386	3,129	1,095	nmf
EBITDA Margin	10.9%	8.1%	8.2%	8.3%	7.5%	1.0%	6.6%	2.4%
Total D&A	0	0	0	0	0	0	0	0
EBIT / Operating Income	4,181	3,055	3,550	3,304	3,488	386	3,129	1,095	nmf
Total Interest Income	72	74	435	1,340	0	0	208	42	nmf
Total Interest Expense	0	0	0	0	1,016	788	0	0	-22.4%
Total Other Income	247	115	79	918	4,738	879	1,112	703	+16.1%
Profit Before Tax	4,356	3,014	4,064	5,562	7,210	477	4,449	350	nmf
Total Income Tax	0	0	0	0	555	0	67	643	+5.0%
Net Profit / (Loss)	4,356	3,014	4,064	5,562	6,655	477	4,382	993	nmf
Net Margin	11.4%	8.0%	9.4%	14.0%	14.2%	1.2%	9.3%	2.2%
Other Comprehensive Income	0	0	1,697	0	0	0	0	0
Total Comprehensive Income	4,356	3,014	5,761	5,562	6,655	477	4,382	993	nmf